Merck KGaA's manufacturing group could see billions from COVID-19 work: analyst

Merck KGaA's manufacturing group could see billions from COVID-19 work: analyst

Source: 
Fierce Pharma
snippet: 

COVID-19 vaccines are moving forward at record speeds, but market watchers have cautioned about the looming manufacturing challenges. Merck KGaA, with its manufacturing services outfit, could see billions of dollars in revenue as it assists certain players with their scale-up, an analyst says.